NYSE:RBOT - New York Stock Exchange, Inc. - US92561V2088 - Common Stock - Currency: USD
NYSE:RBOT (5/1/2025, 3:24:35 PM)
8
-0.26 (-3.15%)
The current stock price of RBOT is 8 USD. In the past month the price increased by 29.47%. In the past year, price decreased by -11.3%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.4 | 227.14B | ||
ISRG | INTUITIVE SURGICAL INC | 68.07 | 186.31B | ||
BSX | BOSTON SCIENTIFIC CORP | 38.42 | 153.42B | ||
SYK | STRYKER CORP | 30.76 | 143.14B | ||
MDT | MEDTRONIC PLC | 15.67 | 107.35B | ||
BDX | BECTON DICKINSON AND CO | 12.4 | 49.53B | ||
EW | EDWARDS LIFESCIENCES CORP | 29.11 | 44.49B | ||
IDXX | IDEXX LABORATORIES INC | 41.72 | 38.03B | ||
RMD | RESMED INC | 26.14 | 34.86B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 14.8 | 31.18B | ||
DXCM | DEXCOM INC | 42.76 | 27.67B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.81 | 23.48B |
Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Waltham, Massachusetts and currently employs 123 full-time employees. The company went IPO on 2020-09-04. The firm is combining advanced miniaturized robotics, computer science, sensing and three-dimensional (3D) visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.8 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.
VICARIOUS SURGICAL INC-A
78 Fourth Avenue
Waltham MASSACHUSETTS US
CEO: David Chu
Employees: 129
Company Website: https://www.vicarioussurgical.com/
Investor Relations: https://investor.vicarioussurgical.com/
Phone: 16178681700
The current stock price of RBOT is 8 USD. The price decreased by -3.15% in the last trading session.
The exchange symbol of VICARIOUS SURGICAL INC-A is RBOT and it is listed on the New York Stock Exchange, Inc. exchange.
RBOT stock is listed on the New York Stock Exchange, Inc. exchange.
9 analysts have analysed RBOT and the average price target is 10.97 USD. This implies a price increase of 37.06% is expected in the next year compared to the current price of 8. Check the VICARIOUS SURGICAL INC-A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
VICARIOUS SURGICAL INC-A (RBOT) has a market capitalization of 47.44M USD. This makes RBOT a Nano Cap stock.
VICARIOUS SURGICAL INC-A (RBOT) currently has 129 employees.
VICARIOUS SURGICAL INC-A (RBOT) has a support level at 8.25 and a resistance level at 8.48. Check the full technical report for a detailed analysis of RBOT support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
RBOT does not pay a dividend.
VICARIOUS SURGICAL INC-A (RBOT) will report earnings on 2025-08-11, after the market close.
VICARIOUS SURGICAL INC-A (RBOT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-10.85).
The outstanding short interest for VICARIOUS SURGICAL INC-A (RBOT) is 3.33% of its float. Check the ownership tab for more information on the RBOT short interest.
ChartMill assigns a technical rating of 3 / 10 to RBOT. When comparing the yearly performance of all stocks, RBOT is a bad performer in the overall market: 80.66% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to RBOT. While RBOT has a great health rating, there are worries on its profitability.
Over the last trailing twelve months RBOT reported a non-GAAP Earnings per Share(EPS) of -10.85. The EPS increased by 26.19% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -93.36% | ||
ROE | -135.39% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 78% to RBOT. The Buy consensus is the average rating of analysts ratings from 9 analysts.